Clinical trial
Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
NCT01155492 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Increased Gut Permeability to Lipopolysaccharides (LPS) in Parkinson's Disease
- Lead sponsor
- Rush University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2007
- Completion date
- February 28, 2013
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
multiple system atrophy, parkinson's disease